Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9462437rdf:typepubmed:Citationlld:pubmed
pubmed-article:9462437lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:9462437lifeskim:mentionsumls-concept:C0024432lld:lifeskim
pubmed-article:9462437lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:9462437lifeskim:mentionsumls-concept:C0036576lld:lifeskim
pubmed-article:9462437lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:9462437lifeskim:mentionsumls-concept:C1373120lld:lifeskim
pubmed-article:9462437pubmed:issue6lld:pubmed
pubmed-article:9462437pubmed:dateCreated1998-3-12lld:pubmed
pubmed-article:9462437pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:abstractTextUnlike the selection of HIV-1 variants resistant to anti-retroviral drugs in human peripheral blood mononuclear cells and T cell lines, induction of resistance in monocyte-derived macrophages has not been widely studied. Since macrophages serve as a potential HIV-1 reservoir in humans, knowledge of the effect of anti-retroviral drugs on macrophage-tropic HIV-1 isolates may help in the design of a strategy for prolonged suppression of viral replication. In-vitro selection and drug susceptibility testing of macrophage-tropic HIV-1 variants with reduced sensitivity to two non-nucleoside reverse transcriptase inhibitors, atevirdine and delavirdine (both bis-heteroarylpiperazines), is described here. The atevirdine-resistant isolate was cross-resistant to delavirdine, and the delavirdine-resistant isolate was cross-resistant to atevirdine. Interestingly, the atevirdine-resistant isolate, but not the delavirdine-resistant isolate, was also cross-resistant to nevirapin while the inhibition of viral replication of both isolates in macrophages by zidovudine was the same as that in the parental HIV-1 strain. Nucleotide sequence analysis of the resistant macrophage-tropic HIV-1 isolates showed that the atevirdine-induced resistance was due to a single amino acid change at codon 106 and that the delavirdine-induced resistance could be attributed to an amino acid change at codon 236. This study demonstrates that monocyte-derived macrophages can be used to investigate the phenotypic and genotypic acquisition of anti-retroviral drug resistance of macrophage-tropic HIV-1.lld:pubmed
pubmed-article:9462437pubmed:languageenglld:pubmed
pubmed-article:9462437pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:citationSubsetIMlld:pubmed
pubmed-article:9462437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462437pubmed:statusMEDLINElld:pubmed
pubmed-article:9462437pubmed:monthDeclld:pubmed
pubmed-article:9462437pubmed:issn0305-7453lld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:VerhoefJJlld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:BoucherC ACAlld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:SchuurmanRRlld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:BorleffsJ CJClld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:NottetH SHSlld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:de GraafLLlld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:Been-TiktakA...lld:pubmed
pubmed-article:9462437pubmed:authorpubmed-author:de HaasC JCJlld:pubmed
pubmed-article:9462437pubmed:issnTypePrintlld:pubmed
pubmed-article:9462437pubmed:volume40lld:pubmed
pubmed-article:9462437pubmed:ownerNLMlld:pubmed
pubmed-article:9462437pubmed:authorsCompleteYlld:pubmed
pubmed-article:9462437pubmed:pagination847-53lld:pubmed
pubmed-article:9462437pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:meshHeadingpubmed-meshheading:9462437-...lld:pubmed
pubmed-article:9462437pubmed:year1997lld:pubmed
pubmed-article:9462437pubmed:articleTitleIn-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages.lld:pubmed
pubmed-article:9462437pubmed:affiliationEijkman-Winkler Institute of Medical Microbiology, University of Utrecht, University Hospital, The Netherlands.lld:pubmed
pubmed-article:9462437pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9462437pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9462437pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9462437lld:pubmed